Sugi Predict

Sugi Predict / Compounds / SCHEMBL7447496

SCHEMBL7447496

SCHEMBL7447496

CSCCC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCC(N)=O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)C(Cc1ccccc1)NC(=O)C(C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(NC(=O)C(CCC(=O)O)NC(=O)C(C)N)C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 11/20 0.53
▸ SCTR P47872 1/20 0.53
▸ GCGR P47871 1/20 0.52
▸ GIPR P48546 1/20 0.52
▸ KEAP1 Q14145 1/20 0.52
▸ PTH1R Q03431 1/20 0.49
▸ VIPR1 P32241 2/20 0.48
▸ VIPR2 P41587 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7447502 1.00 GLP1R (0.53) GLP1RSCTRGCGRGIPRKEAP1
SCHEMBL7454951 0.94 GLP1R (0.55) GLP1RSCTRGCGRGIPRKEAP1
SCHEMBL7454936 0.94 GLP1R (0.55) GLP1RSCTRGCGRGIPRKEAP1
SCHEMBL29934195 0.91 GLP1R (0.51) GLP1RSCTRGCGRGIPRKEAP1
SCHEMBL8427711 0.88 KEAP1 (0.56) GLP1RSCTRGCGRGIPRKEAP1
SCHEMBL31182649 0.88 GLP1R (0.61) GLP1RSCTRGCGRGIPRKEAP1
SCHEMBL29382235 0.86 GLP1R (0.50) GLP1RSCTRKEAP1
SCHEMBL29742728 0.86 VIPR2 (0.57) GLP1RSCTRGCGRGIPRKEAP1
SCHEMBL29655666 0.86 CTSL (0.46) GLP1RSCTRKEAP1PTH1R
SCHEMBL31139979 0.86 GLP1R (0.66) GLP1RSCTRGCGRGIPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1102788-A4 PREVENTION AND TREATMENT OF VIRAL DISEASE UNIV MONTANA (US) 2002-08-28 — — EP disclosed
WO-2000008043-A9 PREVENTION AND TREATMENT OF VIRAL DISEASE UNIV MONTANA (US) 2001-12-13 — — WO disclosed
EP-1102788-A2 PREVENTION AND TREATMENT OF VIRAL DISEASE THE UNIVERSITY OF MONTANA (US) 2001-05-30 — — EP disclosed
WO-2000008043-A2 PREVENTION AND TREATMENT OF VIRAL DISEASE THE UNIVERSITY OF MONTANA (US) 2000-02-17 — — WO disclosed
Send feedback